Accuray, Inc. is a cutting-edge healthcare company based in the United States, specializing in radiation oncology. Their innovative treatment solutions, including The CyberKnife technology, set the standard for radiation therapy care. With an ESG score of 31.6, the company is committed to sustainability and governance practices. Accuray's high-risk profile reflects their dedication to providing precise and effective treatment options for cancer patients, allowing them to live improved lives.